Position in ZTS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$372,953
-$376,498 QoQ
Shares Held
5,190
-18.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#858
of 1,414 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Chicago Partners Investment Group LLC holds $3,695,869 across 13 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
8,472 | $1,427,870 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,179 | $638,817 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
15,434 | $379,830 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
5,190 | $372,953 | |
| 5 | VTRS |
Viatris Inc
|
15,036 | $238,771 | |
| 6 | EOLS |
Evolus, Inc.
|
22,248 | $154,401 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
14,488 | $144,880 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
11,425 | $90,486 |
All Filings in ZTS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $372,953 | 5,190 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $749,451 | 6,340 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $535,238 | 4,254 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,029,214 | 7,034 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $761,971 | 4,886 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $481,601 | 2,925 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $428,994 | 2,633 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $491,966 | 2,518 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $390,580 | 2,253 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $360,248 | 2,129 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $418,424 | 2,120 | Shares | Sole | 2024-02-23 | |
| 2023-09-30 | $426,772 | 2,453 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $419,847 | 2,438 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $429,248 | 2,579 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $334,427 | 2,282 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $339,287 | 2,288 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $300,635 | 1,749 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $341,913 | 1,813 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $438,277 | 1,796 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $333,144 | 1,716 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $307,494 | 1,650 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $251,968 | 1,600 | Shares | Sole | 2021-04-28 | |
| No filing history on record for this holder in this stock. | ||||||